Autopsy report · NCT06445543

Nutrition Optimization and Community Upliftment for Postpartum Recovery: Hypertension

“Funding was cut”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Johns Hopkins University

Sponsor type

University, hospital or other

Conditions

Obesity, Maternal; Pre-Eclampsia; Complicating Pregnancy; Gestational Hypertension; Eclampsia; Complicating Pregnancy

Interventions

MFeast ENHANCED; MFeast Usual Care

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Clinical, Pharmacological and Molecular Effects of IV and Oral Acetaminophen in Adults With aSAH
  “Funding was stopped” (83% match in meaning)
• Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter
  “Funding Stopped” (79% match in meaning)
• Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer
  “funding was withdrawn” (78% match in meaning)
• Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure
  “Funding ceased” (78% match in meaning)
• Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery
  “Ran out of funding” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.